After several weeks of range-bound movement, shares in Sartorius Stedim Biotech could enter into a new clear trend. The exit out of the current trading range could be the signal for a return of. | June 2, 2023
Initially Neutral on the company, Credit Suisse s analyst Dominic Lunn maintained his recommendation. The target price is reduced from EUR 360 to EUR 320. | April 18, 2023
By Cecilia Butini Shares in German pharmaceutical and laboratory equipment supplier Sartorius AG and its France-listed subsidiary Sartorius Stedim Biotech SA fell in opening trade on Friday. | March 31, 2023